ASRS
CRNX

Arizona State Retirement System’s Crinetics Pharmaceuticals CRNX Stock Holding History

Arizona State Retirement System’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$946K Buy
25,280
+706
+3% +$26.2K ﹤0.01% 1205
2026
Q1 		$893K Sell
24,574
-440
-2% -$19.7K 0.01% 1149
2025
Q4 		$1.16M Sell
25,014
-1,286
-5% -$57.3K 0.01% 1034
2025
Q3 		$1.1M Buy
26,300
+504
+2% +$16.1K 0.01% 1088
2025
Q2 		$742K Buy
25,796
+1,897
+8% +$58.6K ﹤0.01% 1264
2025
Q1 		$802K Buy
23,899
+430
+2% +$16.1K 0.01% 1173
2024
Q4 		$1.2M Buy
23,469
+4,168
+22% +$233K 0.01% 1009
2024
Q3 		$986K Buy
19,301
+758
+4% +$39.1K 0.01% 1106
2024
Q2 		$831K Buy
18,543
+958
+5% +$44.2K 0.01% 1134
2024
Q1 		$823K Buy
17,585
+2,796
+19% +$109K 0.01% 1148
2023
Q4 		$526K Sell
14,789
-281
-2% -$8.62K ﹤0.01% 1415
2023
Q3 		$448K Buy
15,070
+4,471
+42% +$92.1K ﹤0.01% 1444
2023
Q2 		$191K Sell
10,599
-315
-3% -$6.28K ﹤0.01% 1970
2023
Q1 		$175K Buy
10,914
+297
+3% +$5.5K ﹤0.01% 1970
2022
Q4 		$194K Buy
10,617
+439
+4% +$7.74K ﹤0.01% 1929
2022
Q3 		$200K Buy
10,178
+100
+1% +$2.04K ﹤0.01% 1888
2022
Q2 		$188K Buy
+10,078
New +$201K ﹤0.01% 1955
2022
Q1 		– Sell
-8,693
Closed -$247K – 2242
2021
Q4 		$247K Buy
+8,693
New +$214K ﹤0.01% 1957

Other funds holding CRNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JT
Jupiter Topco New York $245B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Arizona State Retirement System's CRNX Position: Q2 2026 in Review

Arizona State Retirement System increased its Crinetics Pharmaceuticals (CRNX) stake by 2.9% in Q2 2026, buying an estimated $26.2K and bringing the position to 25,280 shares worth $946K. The position accounts for ﹤0.01% of the portfolio, ranked #1205.

Arizona State Retirement System first reported a position in CRNX in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.2M in Q4 2024. 267 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

  • Arizona State Retirement System held 25,280 shares of Crinetics Pharmaceuticals worth $946K as of Q2 2026.
  • Arizona State Retirement System bought 706 Crinetics Pharmaceuticals shares in Q2 2026, an estimated $26.2K.
  • Crinetics Pharmaceuticals made up ﹤0.01% of Arizona State Retirement System's portfolio in Q2 2026, its #1205 holding.
  • Arizona State Retirement System first reported a position in Crinetics Pharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • Arizona State Retirement System's Crinetics Pharmaceuticals position peaked at $1.2M in Q4 2024.
  • 267 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on Arizona State Retirement System's 13F filing for Q2 2026, filed 7 Aug 2026.